ABOUT US
About MUVON
Therapeutics
MUVON Therapeutics is a clinical stage Life Science Spin-off from the University of Zurich developing a novel therapy platform for the regeneration of skeletal muscle tissue based on autologous cells. We aim to provide safe, effective and affordable treatments to millions of patients suffering from seriously debilitating diseases by not only repairing damaged tissue but also increase the regenerative potential of weakened muscles. Our initial area of focus is the treatment of stress urinary incontinence in women, supporting them respectfully throughout their journey to a healthy life.
Management
Deana Mohr, PhD
CEO & Co-Founder
Deana Mohr serves as Chief Executive Officer of MUVON Therapeutics since its founding in 2020. With over 15 years of experience in regenerative medicine therapy development, she brings deep scientific, clinical, and operational expertise.... more
Christine Günther, MD PhD
CTO
Christine combines a rare blend of medical innovation and technology leadership and a proven track record as a biotech entrepreneur, scaling sustainable cell therapy businesses from startup to exit... more
Steve Kappenthuler, PhD
COO/CFO & Co-Founder
Steve joined the founding team in 2019, playing a pivotal role in crafting the MUVON’s business plan prior to the company's official incorporation in 2020. Since founding MUVON, Steve has served across multiple C-suite functions... more
Board of Directors
Thomas Meier, PhD
Chairman
Thomas has over 25 years of entrepreneurial, strategic and operational experience leading innovative biopharmaceutical companies through transitional periods in their corporate development and to rapid growth. more
Jonathan Grahm
​
Jonathan studied Business Administration at the University of St. Gallen (HSG) and holds a Master’s degree in Marketing, Services & Communications Management. He is currently CMO ... more
Deana Mohr, PhD
Deana has been central to the development of the science behind MUVON from the very beginning. The results of her seminal PhD thesis were the final step before the authorization... more
Branimir Brankov, PhD
Branimir Brankov is a Pharma industry leader, a Medical Doctor with 30+ years of Pharmaceutical industry experience. His experience includes... establishing and turning around business in multiple therapies ... more
Advisory Board
Prof. Christopher R. Chapple,
BSc MBBS MD FRCS (Urol) FEBU DHC
Christopher Chapple is a Consultant Urological Surgeon at Sheffield Teaching Hospitals, Honorary Professor at University of Sheffield and Visiting Professor at Sheffield Hallam University. He is particularly interested in... more
Dorothea Ledergerber, PhD
Dorothea is a C-Suite and Board level experienced Pharmacist with extensive practice in research, development, manufacturing and supply of pharmaceutical products. Her background spans a
wide range of accountabilities in the field of small molecules and cell & gene therapies....more
Prof. Grannum R. Sant,MA, MB BCh BAO (Hons), MD, FRCS, FACS
Grannum is Professor and former Chair of Urology and Urology Residency Program Director at Tufts University School of Medicine. He graduated MB, BCh, BAO (Hons.) and M.D. (by thesis) from... more
Cornelia Betschart, Prof Dr. med
Prof Dr. med. Cornelia Betschart Meier, MD completed her specialist training in Obstetrics and Gynecology in 2006. For her subspecialty training in Urogynecology she did a Research Fellowship from 2011-2013 ... more
Prof. Daniel Eberli, MD PhD
Prof. Daniel Eberli, MD, PhD, is Senior Attending Physician at the Department of Urology (University Hospital Zurich) since 2011. He founded the Laboratory for Stem Cell Therapy and Tissue Engineering (2008) ... more
Christoph Herwig, PhD
Christoph Herwig is a distinguished bioprocess engineer with a Dipl. Ing. from RWTH Aachen and a PhD in bioprocess identification from EPFL, Switzerland. From 2008 to 2023, he served as a full professor of biochemical engineering at the Vienna University of Technology...more
Prof. Stergios Doumouchtsis,
MD PhD
Prof. Stergios Doumouchtsis is currently a Consultant Obstetrician Gynaecologist and subspecialist Urogynaecologist in the Department of Obstetrics and Gynaecology, Epsom & St Helier University Hospitals NHS Trust... more
Prof. Philip E.V. van Kerrebroek, MD PhD
Prof. Philip E.V. van Kerrebroeck is an internationally recognized urologist and academic renowned for his contributions to functional and neuro-urology. He served for many years as Professor and Chair of Urology at Maastricht University Medical Center... more